Literature DB >> 19533258

Precision-cut slice cultures of tumors from MMTV-neu mice for the study of the ex vivo response to cytokines and cytotoxic drugs.

Nirmala Parajuli1, Wolfgang Doppler.   

Abstract

Ex vivo analysis of signaling pathways operating in tumor tissue is complicated by the three-dimensional structure, in particular by stroma-epithelial interactions. Studies performed with pure populations of tumor cells usually do not take into account this issue. One possibility to preserve the tissue architecture is the use of tumor slices. However, diffusion of oxygen and nutrients may become limiting factors, resulting in decreased cell viability and change of tissue morphology, especially after long-term incubation of slices. By using precision cut slices of defined thickness, we were able to establish culture conditions for tumor material obtained from MMTV-neu transgenic mice, which allow the study of the action of cytokines and cytotoxic drugs for up to 24 h. A slice thickness of 160 mum was found to be optimal for viability and handling of material. These slices were highly responsive to the action of the cytokine IFN-gamma, as evident form the increase of pY701 STAT1, detected by both immunohistochemistry and western blotting, and by the increase of mRNA levels of the IFN-gamma response genes IRF-1, SOCS-1, and STAT1, analyzed by reverse transcriptase-polymerase chain reaction. Furthermore, induction of apoptosis and increase of DNA damage could be monitored after treatment with IFN-gamma or doxorubicin. The slices were also a convenient source for the establishment of explant cultures of tumor epithelial cells. It is concluded that cultivation of precision-cut tumor slices provides a convenient way for the ex vivo molecular analysis of MMTV-neu tumor tissue under conditions which closely simulate the situation in vivo and can provide an alternative to in vivo experiments.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19533258     DOI: 10.1007/s11626-009-9212-7

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  30 in total

Review 1.  Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis.

Authors:  Laura Kass; Janine T Erler; Micah Dembo; Valerie M Weaver
Journal:  Int J Biochem Cell Biol       Date:  2007-07-19       Impact factor: 5.085

2.  Comparison of five incubation systems for rat liver slices using functional and viability parameters.

Authors:  P Olinga; K Groen; I H Hof; R De Kanter; H J Koster; W R Leeman; A A Rutten; K Van Twillert; G M Groothuis
Journal:  J Pharmacol Toxicol Methods       Date:  1997-10       Impact factor: 1.950

Review 3.  Precision-cut tissue slices: applications in pharmacology and toxicology.

Authors:  A R Parrish; A J Gandolfi; K Brendel
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

4.  Ex vivo analysis of antineoplastic agents in precision-cut tissue slices of human origin: effects of cyclooxygenase-2 inhibition in hepatocellular carcinoma.

Authors:  Michael A Kern; Anke M Haugg; Eva Eiteneuer; Elisabeth Konze; Uta Drebber; Hans P Dienes; Kai Breuhahn; Peter Schirmacher; Hans U Kasper
Journal:  Liver Int       Date:  2006-06       Impact factor: 5.828

5.  A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity.

Authors:  Tyler O Kirby; Angel Rivera; Daniel Rein; Minghui Wang; Ilya Ulasov; Martina Breidenbach; Manjula Kataram; Juan L Contreras; Carlos Krumdieck; Masato Yamamoto; Marianne G Rots; Hidde J Haisma; Ronald D Alvarez; Parameshwar J Mahasreshti; David T Curiel
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

6.  Interaction and functional interference of glucocorticoid receptor and SOCS1.

Authors:  Michael C Haffner; Andreas Jurgeit; Chiara Berlato; Stephan Geley; Nirmala Parajuli; Akihiko Yoshimura; Wolfgang Doppler
Journal:  J Biol Chem       Date:  2008-06-04       Impact factor: 5.157

7.  Herpes simplex virus type 1 preferentially targets human colon carcinoma: role of extracellular matrix.

Authors:  Dror Kolodkin-Gal; Gideon Zamir; Yair Edden; Eli Pikarsky; Alon Pikarsky; Hillel Haim; Yosef S Haviv; Amos Panet
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

8.  Culturing precision-cut human prostate slices as an in vitro model of prostate pathobiology.

Authors:  A R Parrish; K Sallam; D W Nyman; J Orozco; A E Cress; B L Dalkin; R B Nagle; A J Gandolfi
Journal:  Cell Biol Toxicol       Date:  2002       Impact factor: 6.691

9.  Preferential inhibition of inducible nitric oxide synthase in intact cells by the 4-amino analogue of tetrahydrobiopterin.

Authors:  K Schmidt; G Werner-felmayer; B Mayer; E R Werner
Journal:  Eur J Biochem       Date:  1999-01

Review 10.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its therapeutic potential in breast and gynecologic cancers.

Authors:  James E Kendrick; Jacob M Estes; J Michael Straughn; Ronald D Alvarez; Donald J Buchsbaum
Journal:  Gynecol Oncol       Date:  2007-06-29       Impact factor: 5.482

View more
  13 in total

1.  Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies.

Authors:  Inge A M de Graaf; Peter Olinga; Marina H de Jager; Marjolijn T Merema; Ruben de Kanter; Esther G van de Kerkhof; Geny M M Groothuis
Journal:  Nat Protoc       Date:  2010-08-19       Impact factor: 13.491

2.  Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.

Authors:  José M A Moreira; Teresa Cabezón; Irina Gromova; Pavel Gromov; Vera Timmermans-Wielenga; Isidro Machado; Antonio Llombart-Bosch; Niels Kroman; Fritz Rank; Julio E Celis
Journal:  Mol Oncol       Date:  2010-10-08       Impact factor: 6.603

3.  Parallel microfluidic chemosensitivity testing on individual slice cultures.

Authors:  Tim C Chang; Andrei M Mikheev; Wilson Huynh; Raymond J Monnat; Robert C Rostomily; Albert Folch
Journal:  Lab Chip       Date:  2014-10-02       Impact factor: 6.799

Review 4.  Technologies for deriving primary tumor cells for use in personalized cancer therapy.

Authors:  Abhisek Mitra; Lopa Mishra; Shulin Li
Journal:  Trends Biotechnol       Date:  2013-04-16       Impact factor: 19.536

5.  The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer.

Authors:  J L Schwartz; A N Shajahan; R Clarke
Journal:  Int J Breast Cancer       Date:  2011-07-03

6.  Organotypic culture of breast tumor explants as a multicellular system for the screening of natural compounds with antineoplastic potential.

Authors:  Irma Edith Carranza-Torres; Nancy Elena Guzmán-Delgado; Consuelo Coronado-Martínez; José Inocente Bañuelos-García; Ezequiel Viveros-Valdez; Javier Morán-Martínez; Pilar Carranza-Rosales
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

7.  Vitamin C acts as a hepatoprotectant in carbofuran treated rat liver slices in vitro.

Authors:  Sunil Kumar Jaiswal; Vivek Kumar Gupta; Md Dilshad Ansari; Nikhat J Siddiqi; Bechan Sharma
Journal:  Toxicol Rep       Date:  2017-06-09

8.  Patient-derived ovarian cancer explants: preserved viability and histopathological features in long-term agitation-based cultures.

Authors:  Sofia Abreu; Fernanda Silva; Rita Mendes; Teresa F Mendes; Marta Teixeira; Vítor E Santo; Erwin R Boghaert; Ana Félix; Catarina Brito
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

Review 9.  Patient-Derived Explants as a Precision Medicine Patient-Proximal Testing Platform Informing Cancer Management.

Authors:  Abby R Templeton; Penny L Jeffery; Patrick B Thomas; Mahasha P J Perera; Gary Ng; Alivia R Calabrese; Clarissa Nicholls; Nathan J Mackenzie; Jack Wood; Laura J Bray; Ian Vela; Erik W Thompson; Elizabeth D Williams
Journal:  Front Oncol       Date:  2021-12-20       Impact factor: 6.244

Review 10.  Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research.

Authors:  James Clark; Christina Fotopoulou; Paula Cunnea; Jonathan Krell
Journal:  Front Oncol       Date:  2022-03-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.